Search

everythinglearnresearchcommunity

for

Search:↓

A postmenopausal woman's excess male hormone symptoms improved after her ovaries were removed.

PCOS women have more severe metabolic issues and higher androgen levels than hyperandrogenic women without PCOS.

Treating early puberty with hormone therapy may increase the risk of polycystic ovary syndrome in adults.

Removing the ovaries can help treat hair loss caused by high androgen levels in postmenopausal women.

Most patients improved with oral contraceptives, but some needed additional treatment.

Deslorelin can help control reproduction and improve hair growth in German Spitz dogs.

A pineal tumor caused a boy's early puberty, which changed from peripheral to central after treatment.

Hormones control reproduction and are crucial for body balance.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The document concludes that proper diagnosis and a multidisciplinary approach are crucial for managing Congenital Adrenal Hyperplasia effectively.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Diagnosing sex development disorders requires combining medical history, physical exams, imaging, lab tests, and genetic data.

Low-dose Buserelin effectively reduces hirsutism with minimal side effects.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Elagolix did not effectively treat polycystic ovary syndrome.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

Reference values for nine hormones were established to help diagnose PCOS.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Clomiphene testing can help find ovarian causes of high testosterone in postmenopausal women.

High testosterone increases heart disease risk in women with PCOS.